BS_J6VKB1VE
low-grade glioma
Clinical attributes
From the source cohort, normalized into canonical keys plus the project's native columns.
- cancer_type
- low-grade glioma
- cancer_type_detailed
- —
- subtype
- —
- cancer_type
- low-grade glioma
- age_years
- 8.238
- sex
- Male
GSVA pathway preview (0 Hallmark scores)
Top 10 most elevated and top 10 most suppressed Hallmark pathways for this sample.
Patient twins — nearest pathway neighbors
10 samples closest to this one in 50-dim pathway space, drawn from the Pathway Atlas. Cosine similarity = 1 means identical pathway state.
10 twins match this tumor's tissue · 0 come from a different tissue of origin
| # | Sample | Cancer type | Subtype | cos similarity |
|---|---|---|---|---|
| 1 | SRR1313132 | — | D | 0.891 |
| 2 | be8d8236-4ebc-46de-a4fd-a901fec1cdce | — | — | 0.888 |
| 3 | BS_25T139TX | low-grade glioma | — | 0.869 |
| 4 | SRR8518220 | — | D | 0.869 |
| 5 | bae6fdb5-9df3-433c-9a4c-e5c159a62bc6 | — | — | 0.864 |
| 6 | TCGA-93-A4JQ-01A-11R-A24X-07 | — | cohortA1 | 0.863 |
| 7 | e07c111b-da6e-4743-9351-77491153bec4 | — | — | 0.859 |
| 8 | AUR-AE6X-TTP1-A-1-0-R-A741-41 | — | D | 0.857 |
| 9 | TCGA-93-A4JO-01A-21R-A24X-07 | — | cohortA1 | 0.857 |
| 10 | C3N-00433 | — | cohortMD2 | 0.856 |
Per-pathway drug coverage
For each elevated pathway in this tumor, the best-reversing drug across the catalog. Uncovered pathways = unmet need at pathway level for this one patient.
0 of 15 elevated pathways have at least one drug that meaningfully reverses them.
| Pathway (elevated) | tumor score | Best drug | reversal magnitude |
|---|---|---|---|
| INTERFERON_ALPHA_RESPONSE | 0.399 | Inavolisib | — uncovered |
| INTERFERON_GAMMA_RESPONSE | 0.399 | Idelalisib | — uncovered |
| ALLOGRAFT_REJECTION | 0.314 | Idelalisib | — uncovered |
| IL6_JAK_STAT3_SIGNALING | 0.300 | Inavolisib | — uncovered |
| INFLAMMATORY_RESPONSE | 0.213 | Idelalisib | — uncovered |
| TNFA_SIGNALING_VIA_NFKB | 0.186 | Inavolisib | — uncovered |
| ANGIOGENESIS | 0.171 | Remibrutinib | — uncovered |
| KRAS_SIGNALING_UP | 0.165 | Inavolisib | — uncovered |
| IL2_STAT5_SIGNALING | 0.164 | Idelalisib | — uncovered |
| APICAL_SURFACE | 0.141 | Temsirolimus | — uncovered |
| COMPLEMENT | 0.100 | Inavolisib | — uncovered |
| KRAS_SIGNALING_DN | 0.021 | Remibrutinib | — uncovered |
| NOTCH_SIGNALING | 0.015 | Inavolisib | — uncovered |
| COAGULATION | 0.008 | Binimetinib | — uncovered |
| UV_RESPONSE_DN | 0.005 | Inavolisib | — uncovered |